explore -WSS

explore

author：leisure time 2025-09-29 20:00:08 - browse：9595

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Supreme Court strikes down use of affirmative action
Next article： Affirmative action in medical school literally saved lives

focus

WSS

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Marc Tessier

Timeline: Special counsel's probe into Trump's handling of classified documents

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

George Santos makes 1st court appearance after pleading not guilty to 13 counts

At least 13 dead in Texas as scorching temps continue

explore

explore

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Marc Tessier

Moonlake's readout produced a cash windfall. Risks remain

Biden announces an advanced cancer research initiative

In Memoriam: Notable people who died in 2023

Continuity nursing helped my family in our darkest PICU moments

Walensky prepares to leave CDC — and Congress — behind

Cancer drug shortages should be causing more outrage

United colonoscopy coverage change 'may cost lives,' doctors say

An outrageous hospital charge: I paid $710 for an hour of babysitting

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Behind warning on Apellis’s eye drug lies a conflict of interest

Stoke drug shows lower activity against childhood epilepsy

Ending health disparities requires full federal government, panel says

Timeline: Special counsel's probe into Trump's handling of classified documents

DIEP, the 'gold standard' of breast reconstruction, is under threat

entertainment

focus

hotspot

entertainment